1. Home
  2. SNN

as of 11-20-2026 3:45pm EST

$29.92
+$0.09
+0.30%
Stocks Health Care Industrial Specialties Nasdaq

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.

Founded: 1856 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 12.3B IPO Year: 2002
Target Price: $33.19 AVG Volume (30 days): 1.5M
Analyst Decision: Hold Number of Analysts: 6
Dividend Yield:
2.56%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $26.30 - $37.09 Next Earning Date: 08-04-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 3.93% Revenue Growth (next year): 4.91%
P/E Ratio: 64.97 Index: N/A
Free Cash Flow: N/A FCF Growth: +7.28%

Share on Social Networks: